The note says Chairman and MD Bhavish Aggarwal has pledged a 4.32% stake to participate in the company's rights issue approved on 28 September.
Read this note →Research notes
What India's research desks published, reported with attribution and linked to the original notes. Orivam issues no recommendations of its own.
All houses
HDFC Securities
Motilal Oswal
Mirae Asset Sharekhan
Tata Asset Management
India IPO
Jainam
GEPL Capital
Way2Wealth
SBICAP Securities
Angel One
Axis Securities
ICICI Direct Research Retail
Formerly known as Way2Wealth
Religare
Arete Securities
ICICI Direct
Way2Wealth Securities
ICICI Securities
quant Mutual Fund
Kotak Securities
JM Financial
ICICI Securities – Retail
Ventura Securities
Global Markets by Vested
Prabhudas Lilladher
ITC Hotels
Elara Securities
Exterminators PLC
Emkay Global
Industrial Asphalts
Private Client Group Research summarized from KIE research report
Kahawatte Plantations PLC
1793 notes · 01 Oct 2026, 00:00 to 01 Nov 2026, 00:00 IST
The note says whole-time director Anup Saha will be MD and CEO of the lender for a three-year term.
Read this note →The note says HDFC Bank has appointed ICICI Group veteran Anup Bagchi as its next MD & CEO following RBI approval.
Read this note →The report says Sobha posted Q2FY27 presales of INR 22.1bn (+16% YoY), H1FY27 presales at an all-time high of INR 58.6bn (+47% YoY, 59% of FY27 guidance), a strong launch pipeline (H1 launches of 7.9msf/INR 112bn, ~75% of FY27 guidance), and that margins are expected to improve meaningfully from H2FY27 as the INR186bn unrecognized revenue book with 30%+ project-level EBITDA margins moves into recognition, leading HSIE Research to maintain a BUY rating with a target price of INR 1,930/share.
Read this note →Flagged in the quant intraday sell strategy at close price 2,058.7 with 1% SL and 1% target.
Read this note →Flagged in the quant intraday sell strategy at close price 111 with 1% SL and 1% target.
Read this note →Options-on-radar idea to buy the 3400 PE on short buildup, with target 139.
Read this note →Options-on-radar idea to buy the 1240 PE on short buildup, with target 43.
Read this note →Options-on-radar idea to buy the 940 PE on short buildup, with target 32.
Read this note →Options-on-radar idea to buy the 5250 CE on short covering, with target 164 and SL 115.
Read this note →Options-on-radar idea to buy the 7000 CE on short covering, with target 210 and SL 161.
Read this note →Technical radar note says more momentum above 1,755, holding above 50 DEMA with support at 1,670.
Read this note →Technical radar note says the stock has given a range breakdown with a lower-top-lower-bottom formation and resistance at 11,757.
Read this note →Technical conviction delivery idea citing a box breakout and positive RSI, with SL ₹1,930 over one week.
Read this note →Listed among focus investment ideas with 16% stated upside.
Read this note →Listed among focus investment ideas with 18% stated upside.
Read this note →Listed among focus investment ideas with 23% stated upside.
Read this note →Listed among focus investment ideas with 37% stated upside.
Read this note →Listed among focus investment ideas with 37% stated upside on a one-year horizon.
Read this note →Included at 20% weight in the report's Textile & Apparel basket.
Read this note →Included at 20% weight in the report's Textile & Apparel basket.
Read this note →Included at 20% weight in the report's Textile & Apparel basket.
Read this note →Included at 20% weight in the report's Textile & Apparel basket.
Read this note →Included at 20% weight in the report's Textile & Apparel basket with a 12-month horizon and stated 15-20% upside.
Read this note →A 'Velocity Idea' says Divi's is positioned for peptide/CDMO opportunities and tariff clarity, projecting 21% earnings CAGR over FY26-28, with SL ₹8,870.
Read this note →